Left Ventricular Assist Devices as Permanent Heart Failure Therapy

Posted on October 1st, 2003

The Annals of Surgery concludes the cost of long-term LVAD implantation is commensurate with other life-saving organ transplantation procedures, and will likely continue to decrease in the future.

2003 10-01 Left Ventricular Assist Devices as Permanent Heart Failure Therapy- The Price of Progress

About Anthem Equity Group

Anthem is an open-integrated company where our investors, lenders, vendors and team members are part of a seamless organization, committed to working together to maximize our returns in a climate of opportunity and uncertainty. Today’s modern communication tools form the platform for this strategy.